AGILE THERAPEUTICS INC. news, videos and press releases
For more news please use our advanced search feature.
AGILE THERAPEUTICS INC. - More news...
AGILE THERAPEUTICS INC. - More news...
- STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Agile Therapeutics, Inc. - AGRX
- Thinking about buying stock in Agile Therapeutics, Nano-X Imaging, Eastside Distilling, Root Inc, or GigaCloud Technology?
- Agile Therapeutics Posts Growth In Third Quarter Results, Reiterates Confidence In Target of $25M Net Revenue, Positive Cash Flow In 2024
- Agile Therapeutics (NASDAQ: AGRX) Upgraded To “Buy” Rating By Analysts At Maxim Group
- Agile Says It's On Track To Hit $25-$30 Million Net Annual Revenue After A Strong Performance In Its Second Quarter
- This Reproductive Health Company's Weekly Contraceptive Patch Can Reach Millions of Women Thanks to a Partnership With Afaxys
- Agile Therapeutics Partners With Telehealth Platforms To Expand Access To Weekly Birth Control Patch To Millions Of Women
- Agile Sees Renewed Hope For Even Broader Adoption Of Its Weekly Birth Control Patch After Biden’s Latest Executive Order Expanding Contraceptive Coverage
- H.C. Wainwright Reiterates Buy Rating For Agile Therapeutics (NASDAQ: AGRX), Citing Growing Demand For Twirla, A Weekly Low Dose Birth Control Patch
- This Women's Healthcare Company Raised $7.5 Million In A Public Offering And Says It's Targeting $25 To $30 Million Net Revenue By End Of 2023
- Agile Therapeutics Expects Its Innovative Once-A-Week Birth Control Patch To Drive Revenues Of $25-30 Million In 2023 - What Is The Hype All About?
- The Overturning of Roe v. Wade Has Changed the Landscape of Birth Control; Smaller Companies are now an Integral Part of Care
- EQS-News: This Biotech Company is Pursuing Positive Cash Flow In 2023
- EQS-News: Women’s Healthcare Company Agile Therapeutics Says It Believes It Has An Effective Business Plan In Place For Growth And Generating Positive Cash Flow
- EQS-News: Can This Company’s Birth Control Patch Disrupt The Contraceptive Market?
- EQS-News: NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022
- Thinking about buying stock in Agile Therapeutics, AMC Entertainment, AT&T, Ocugen, or Visa?
- Thinking about buying stock in Kezar Life Sciences, Evofem Biosciences, Agile Therapeutics, Sutro Biopharma, or Wejo Group?
- Thinking about buying stock in Epizyme, Acutus Medical, Agile Therapeutics, Axsome Therapeutics, or Evofem Biosciences?
- Thinking about buying stock in American Airlines, Petroleo Brasileiro, Agile Therapeutics, Uranium Energy, or Ginkgo Bioworks?
- DGAP-News: Agile Therapeutics Partners with Carli Lloyd, U.S. Women's Soccer Star and Four-Time Olympian, to Bring Awareness to Women's Health Topics
- Thinking about buying stock in Geovax Labs, Marker Therapeutics, Agile Therapeutics, FibroGen, or Pixelworks?
- Thinking about buying stock in Avadel Pharmaceuticals, Nikola Corp, Agile Therapeutics, Biocept Inc, or Uber Technologies?
-
Agile Therapeutics, Inc. - AGRX Stock Chart Technical Analysis for 05-01-2020
-
Agile Therapeutics, Inc. - AGRX Stock Chart Technical Analysis for 02-11-2020
-
Agile Therapeutics, Inc. - AGRX Stock Chart Technical Analysis for 01-28-2020
-
Agile Therapeutics, Inc. - AGRX Stock Chart Technical Analysis for 01-24-2020
-
Agile Therapeutics, Inc. - AGRX Stock Chart Technical Analysis for 01-23-2020
-
Agile Therapeutics, Inc. - AGRX Stock Chart Technical Analysis for 01-02-2020
-
Agile Therapeutics, Inc. - AGRX Stock Chart Technical Analysis for 12-24-2019
